Dear Colleagues,
The Fast Forward Medical Innovation team is currently working from home, in alignment with the University of Michigan's policy encouraging telecommuting. We will continue to shepherd the biomedical research enterprise's business development, commercialization, and innovation education needs remotely, so you should not experience any disruption in the services we provide. We encourage you to contact us via email with any concerns.
Due to COVID-19, we have postponed "The Pharmaceutical Industry: Trends, Opportunities, & Challenges" event scheduled for April 2 featuring Paul Hudson, CEO of Sanofi. The event will be rescheduled at a later date.
CLICK HERE for details as they are made available.
We anticipate other changes to FFMI events, classes, and programs in the upcoming weeks and will post all updates on the FFMI website. We want to assure the U-M research community that the Fast Forward Medical Innovation team is still fully functional and here to support your research needs. For the latest in news and developments on the COVID-19 situation at U-M, visit the
U-M Office of Research website and the
Michigan Medicine Office of Research website.
Best Regards,
|
|
Bradley Martin, Ph.D.
Director
Fast Forward Medical Innovation
|
|
DEADLINE EXTENDED - Frankel Innovation Initiative Accepting Proposals
|
|
The Frankel Innovation Initiative is a $20 million fund supporting the research and development of life-saving therapies at Michigan Medicine. The fund targets projects led by U-M faculty that have the potential for rapid clinical application and groundbreaking impact.
Proposals are due Monday, June 1 by 5:00pm
The $20 million gift will be used to fund five to seven projects annually, with each project receiving between $250,000 - $1 million.
|
|
|
Commercialization Education
|
|
FFMI
fast
PACE Fall Cohort Registration Available
|
|
The Winter cohort of the FFMI
fastPACE course wrapped up last week with a virtual finale event where the teams presented their projects.
FFMI
fastPACE is a 4-week biomedical and commercialization course designed to help participants prepare a successful business case for funding and development partnerships.
Registration is now available for the Fall cohort beginning September 25. Sign up today!
|
|
|
Cures Within Reach Offers Funding Opportunities
|
|
Cures Within Reach catalyzes repurposing research to quickly and affordably improve patient lives. Submission deadlines for several funding opportunities are quickly approaching.
- Up to $100,000 for repurposing clinical trials in Meniere's disease - Deadline: April 3
- Up to $50,000 for repurposing preclinical projects in Meniere's disease - Deadline: April 3
- Up to $25,000 for repurposing canine comparative trials - Deadline: April 3
- Up to $50,000 for repurposing research based in the Chicagoland area - Deadline: June 1
|
|
Apply Now for MICHR's Pathway Awards
|
|
Do you need to obtain preliminary data that will strengthen an extramural grant application and help you establish your long-term research goals? To support faculty along their career trajectories, the Michigan Institute for Clinical & Health Research (MICHR) is offering two funding mechanisms - Pathway to First Grant and Pathway to Independence. These awards are intended to support investigators who need to collect additional data to competitively pursue their first extramural grants (such as NIH K or R21) or larger independent grants (such as NIH R01 or similar).
Applications are due Monday, April 13 and must be submitted via UMMS Competition Space.
|
|
Michigan Drug Discovery Early-Stage Grants - Now Accepting Proposals
|
|
Michigan Drug Discovery is currently accepting grant proposals for early-stage drug discovery projects in all therapeutic areas. Up to $65,000 per award is available.
Applications will be accepted through April 20.
The expectation is that most of the awarded funds will be used in U-M core laboratories to accelerate the drug discovery process, with $5,000 available for spending outside of the pre-approved cores.
|
|
|
DEADLINE EXTENDED - Michigan Medicine-PKUHSC Joint Institute Call for Proposals
|
|
The 2020 request for proposals for collaborative research through the Michigan Medicine and Peking University Health Science Center (PKUHSC)
Joint Institute deadline has been extended to May 1, 2020.
Michigan Medicine’s largest international institutional partnership, the Joint Institute, offers Discovery Awards (up to $100,000 a year for two years), Pilot Awards (up to $300,000 a year for two years), and Innovation and Bridge Awards for one-year grants (up to $100,000) to help investigative teams develop new technologies and accelerate translation of research into a product.
DEADLINE: May 1, 2020
|
|
|
To better navigate the complexities of the U-M biomedical research enterprise, visit the
Research Project Lifecycle
. This interactive tool provides an overview of the resources available to you, not only within the Medical School Office of Research but also across the University of Michigan.
|
|
Fast Forward Medical Innovation
is part of the Office of Research, where our mission is to foster an environment of innovation and efficiency that serves the U-M Medical School community and supports biomedical science from insight to impact.
|
|
|
|
|
|
|
